tryptophan methyl ester has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barger, GR; Chakraborty, PK; Juhász, C; Kamson, DO; Lee, TJ; Mittal, S; Muzik, O; Robinette, NL; Snyder, M; Varadarajan, K | 1 |
| Akiyama, Y; Hara, N; Miyazaki, T; Moritake, K; Osago, H; Shibata, T; Tsuchiya, M; Yamada, K | 1 |
2 other study(ies) available for tryptophan methyl ester and Glioma
| Article | Year |
|---|---|
Clinical significance of tryptophan metabolism in the nontumoral hemisphere in patients with malignant glioma.
Topics: Adult; Aged; Brain; Brain Neoplasms; Female; Glioma; Humans; Kynurenine; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Serotonin; Tryptophan | 2014 |
Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation.
Topics: Antineoplastic Agents; Drug Delivery Systems; Glioma; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Tryptophan; Tumor Cells, Cultured | 2009 |